• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Alirocumab
    1 Drug classified under this active ingredient

    All the Active Ingredient Drugs

    Praluent 75, 150 mg
    partial basket chart
    Praluent 75, 150 mg

    Monoclonal Antibody. Alirocumab 75 mg/ml, 150 mg/ml.
    PEN/SYR.: 1,2×75,150 mg/ml
    The usual init. dose is 75 mg admin. SC once every 2 wks.
    Pts. requir. larger LDL-C reduction (>60%) may be started on 150 mg admin.
    SC once every 2 wks.
    The dose can be individual. based on pt. characteristics such as baseline
    LDL-C level, goal of ther. &response. See lit.
    Primary Hypercholesterolaemia (heterozygous familial &non-familial) or mixed dyslipidaemia in adults, as an adjunct to diet:
    - in comb .with a statin or statin with other lipid lowering therapies in patients unable to
    reach LDL-C goals with the max. tolerated dose of a statin or,
    - alone or in comb. with other lipid-low. therapies in pts. who are statin-intoler.
    The effect of the drug on cardiovasc. morbid. and mortal. has not yet been determin.
    C/I: Hypersens.